SB
SRRK icon

Samsara BioCapital’s Scholar Rock SRRK Stock Holding History

Samsara BioCapital’s Portfolio SRRK Stock Details SRRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339M Hold
6,897,652
– – 32.95% 1
2025
Q4 		$304M Buy
6,897,652
+1,284,756
+23% +$48.2M 31.35% 1
2025
Q3 		$209M Hold
5,612,896
– – 27.29% 2
2025
Q2 		$199M Hold
5,612,896
– – 40.66% 1
2025
Q1 		$180M Hold
5,612,896
– – 32.18% 1
2024
Q4 		$243M Sell
5,612,896
-1,175,713
-17% -$38.3M 33.3% 1
2024
Q3 		$54.4M Hold
6,788,609
– – 10.45% 3
2024
Q2 		$56.5M Hold
6,788,609
– – 11.84% 3
2024
Q1 		$121M Hold
6,788,609
– – 18.65% 1
2023
Q4 		$128M Buy
6,788,609
+2,189,781
+48% +$27.2M 19.85% 1
2023
Q3 		$32.7M Hold
4,598,828
– – 9.99% 3
2023
Q2 		$34.7M Hold
4,598,828
– – 6.09% 4
2023
Q1 		$36.8M Hold
4,598,828
– – 7.6% 3
2022
Q4 		$41.6M Hold
4,598,828
– – 8.96% 2
2022
Q3 		$31.9M Hold
4,598,828
– – 7.43% 3
2022
Q2 		$25.2M Buy
4,598,828
+4,259,217
+1,254% +$30.6M 6.73% 3
2022
Q1 		$4.38M Buy
+339,611
New +$5.8M 1.1% 24

Other funds holding SRRK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Samsara BioCapital's SRRK Position: Q1 2026 in Review

Samsara BioCapital held its Scholar Rock (SRRK) position steady in Q1 2026 at 6,897,652 shares worth $339M. The position accounts for 32.95% of the portfolio, ranked #1.

Samsara BioCapital first reported a position in SRRK in Q1 2022 and has held it in 17 quarters since. 274 funds tracked by Wall St. Rank hold SRRK as of Q1 2026.

  • Samsara BioCapital held 6,897,652 shares of Scholar Rock worth $339M as of Q1 2026.
  • Samsara BioCapital left its Scholar Rock share count unchanged in Q1 2026.
  • Scholar Rock made up 32.95% of Samsara BioCapital's portfolio in Q1 2026, its #1 holding.
  • Samsara BioCapital first reported a position in Scholar Rock in Q1 2022 and has held it in 17 quarters since.
  • 274 funds tracked by Wall St. Rank held Scholar Rock as of Q1 2026.

Based on Samsara BioCapital's 13F filing for Q1 2026, filed 15 May 2026.